查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1928584

一次性营养输液袋市场按产品类型、材料、应用和最终用户划分，全球预测（2026-2032）

Disposable Nutrition Infusion Bags Market by Product Type, Material, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年一次性营养输液袋市值为 9.0384 亿美元，预计到 2026 年将成长至 9.6666 亿美元，年复合成长率为 6.72%，到 2032 年将达到 14.2537 亿美元。

关键市场统计数据
基准年 2025 9.0384亿美元
预计年份：2026年 9.6666亿美元
预测年份 2032 1,425,370,000 美元
复合年增长率 (%) 6.72%

本文全面概述了临床、监管和营运因素如何重塑一次性营养输液的应用。

本文概述了临床需求、材料科学和供应链发展三者交汇推动一次性营养输液袋应用的关键因素。输液袋设计和製造技术的进步使得人们更加重视一次性使用产品，这类产品能够加强感染控制、降低交叉感染风险并简化临床工作流程。随着医疗专业人员和采购团队寻求安全、易于操作且能与日益复杂的营养疗法相容的产品，一次性输液袋已从最初的战术性便利转变为肠外营养方案中的战略要素。

材料技术的进步、医疗服务的分散化以及供应链透明度的提高，正在重新定义输液系统的产品选择和采购。

一次性营养输液袋的市场格局正经历变革，这主要归因于多种相互作用的因素。输液袋材料和多隔间结构的科技进步，使得复杂营养疗法的配製更加灵活、无菌，从而减少了床边操作，简化了药物分发流程。此外，灭菌方法和包装完整性的改进也进一步提升了产品的保存期限和运输耐用性。

评估关税调整对整个临床供应链的采购决策、供应商多元化和营运连续性的实际影响

影响医疗设备零件的关税政策的公告和实施，增加了采购决策的复杂性。关税可能会加剧医院采购的成本敏感性，并促使其重新考虑地理采购、近岸外包和供应商多元化等策略。对于製造商和经销商，2025年关税调整的累积影响可能会促使他们重新谈判供应商合约、重新评估零件筹资策略，并加快寻找不受类似关税结构影响的替代材料。

细分市场分析揭示了产品组合、应用环境、最终用户需求和材料选择如何影响设计和商业化策略。

细分市场洞察揭示了产品设计、监管策略和市场定位的关键挑战各不相同。根据产品类型，本市场研究涵盖多腔和单腔配置，其中多腔产品进一步细分为2腔、3腔和4腔及以上型号。这些区分至关重要，因为它们决定了预处理柔软性、按需混合需求以及在复杂治疗方案中减少床边操作的可能性。同时，根据应用场景，该市场研究涵盖三种环境：门诊护理、居家医疗和医院环境。每种环境对便携性、标籤清晰度和在不同操作条件下的稳定性都有不同的要求。

全球主要市场法规环境、采购实务和医疗服务模式的区域差异及其策略意义

区域趋势正在导致管理体制、采购惯例和医疗服务模式出现显着差异。在美洲，一体化的医疗体系、强大的医院网络以及对感染预防和运营效率的重视正在影响采购决策，推动人们对能够减轻分发负担和风险的一次性解决方案的兴趣。该地区的法规结构强调医疗设备安全、无菌处理标准和有据可查的供应链管理，从而创造出产品性能和供应商可靠性至关重要的环境。

竞争格局的特点是材料技术、监管应对力和服务导向方面的差异化，这会影响采购选择和伙伴关係模式。

一次性营养输液袋市场的竞争格局取决于企业展示产品差异化、材料专业知识和供应链可靠性的能力。成功的主要企业将深厚的法规知识与对品质系统和生产规模的投入相结合，从而能够以最小的阻力向临床终端用户提供检验的产品。医疗设备製造商、原料供应商和契约製造製造商之间的策略伙伴关係日益普遍，这有助于快速验证替代材料并扩大多腔体规格的生产规模。

切实可行的、优先考虑的策略措施，旨在加速产品推广应用、加强供应链，并使商业性提案与临床和永续性目标保持一致。

针对行业领导者的具体建议着重于采取切实可行的步骤，以平衡临床需求、供应稳定性和商业性可行性。首先，应优先考虑能够减少床边操作并支持安全给药的设计特性，无论是在医院、门诊或居家照护环境中。清晰易懂、以使用者为中心的标籤和简化的混合机制可以减轻训练负担，并促进分散式照护模式的推广应用。同时，应在研发早期阶段检验可萃取物和可浸出物的材料选择，以简化监管申报流程并最大限度地减少上市后变更管理。

采用相关人员访谈、监管审查和交叉检验相结合的混合方法，确保获得严谨且可操作的市场洞察。

本调查方法融合了定性和定量技术，旨在建立强有力的证据基础，并整合各相关人员的观点。主要研究包括对临床负责人、采购经理和供应链专业人员进行结构化访谈，以了解实际工作中的优先事项和营运限制。这些访谈内容被用来建构一个标准化的评估框架，用于比较供应商的产品属性、监管合规性和服务能力。

整合临床、材料和供应链的洞察，我们展示了多维度策略如何决定长期竞争和市场接受度。

结论总结了临床实践、材料科学和供应链策略中涌现的关键主题。一次性营养输液袋兼顾安全性、便利性和操作效率，其应用受到不断发展的护理模式的影响，这些模式优先考虑分散和感染预防。材料选择，特别是聚烯与聚氯乙烯的选择，仍然是产品性能和监管互动中的核心挑战，而多腔室设计对于复杂的配方而言，仍然具有显着的临床优势。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：一次性营养输液袋市场（依产品类型划分）

  • 多重腔体
    • 两房户型
    • 3个房间
    • 4间或更多房间
  • 单室

9. 一次性营养输液袋市场（依材料分类）

  • 聚烯
  • 聚氯乙烯

第十章 按应用分類的一次性营运输液袋市场

  • 门诊治疗
  • 居家照护
  • 医院

第十一章 一次性营养输液袋市场（以最终用户划分）

  • 门诊手术中心
  • 诊所
  • 居家医疗
  • 医院

第十二章：按地区分類的一次性整合输液袋市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 一次性营养输液袋市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国一次性营养输液袋市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

15. 美国一次性营养输液袋市场

第十六章 中国一次性营养输液袋市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AdvaCare Pharma, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Cisen Pharmaceutical Co., Ltd.
  • Fresenius Kabi AG
  • Grifols, SA
  • Huaren Pharmaceutical Co., Ltd.
  • ICU Medical, Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • PolyCine GmbH
  • Renolit SE
  • Romsons International Pvt. Ltd.
  • Shandong Weigao Group Medical Polymer Company Limited
  • Shijiazhuang Pharmaceutical Group Co., Ltd.
  • Sippex SA
  • Technoflex SAS
  • Terumo Corporation
  • Wipak Group
Product Code: MRR-92740D85F04C

The Disposable Nutrition Infusion Bags Market was valued at USD 903.84 million in 2025 and is projected to grow to USD 966.66 million in 2026, with a CAGR of 6.72%, reaching USD 1,425.37 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 903.84 million
Estimated Year [2026] USD 966.66 million
Forecast Year [2032] USD 1,425.37 million
CAGR (%) 6.72%

A comprehensive contextual overview of clinical, regulatory, and operational drivers reshaping adoption of single-use nutrition infusion solutions

The introduction frames the critical context for disposable nutrition infusion bags as a convergence of clinical need, materials science, and supply chain evolution. Advances in bag design and manufacturing have increasingly emphasized single-use formats that address infection control, reduce cross-contamination risk, and simplify clinical workflows. As clinicians and procurement teams seek products that balance safety, handling efficiency, and compatibility with increasingly complex nutrition regimens, disposable bags have moved from a tactical convenience to a strategic component of parenteral nutrition programs.

Concurrently, regulatory attention to device labeling, extractables and leachables, and sterilization validation has intensified, prompting manufacturers to refine materials and process controls. This regulatory focus reinforces clinical confidence in new product introductions while also raising the bar for evidentiary support and post-market surveillance. Operational stakeholders must therefore weigh the clinical advantages against sterility assurance, storage logistics, and procurement policies to ensure seamless adoption.

Looking ahead, the dynamics of staff shortages and heightened infection prevention protocols are likely to sustain interest in single-use infusion solutions. At the same time, decision-makers must continuously reconcile clinical preferences with cost management and environmental considerations, leading to nuanced product selection and contracting strategies.

How advances in materials, decentralization of care, and supply chain transparency are jointly redefining product choice and procurement for infusion systems

The landscape for disposable nutrition infusion bags is undergoing transformative shifts driven by multiple intersecting forces. Technological refinement in bag materials and multi-chamber configurations is enabling more flexible and sterile preparation of complex nutrition regimens, which in turn reduces bedside manipulation and streamlines pharmacy compounding practices. These innovations are complemented by improvements in sterilization methods and packaging integrity, enhancing product shelf life and transport resilience.

Simultaneously, healthcare delivery models are decentralizing, with greater emphasis on home care and ambulatory settings. This transition incentivizes designs that support safe administration outside the traditional hospital environment and that align with patient mobility and caregiver convenience. The expansion of home-based parenteral nutrition programs also draws increased attention to simplified instructions for use, tamper-evident features, and interoperability with infusion pumps used across care settings.

Another pivotal shift is the heightened need for supply chain transparency and vertical traceability. Stakeholders now demand clearer provenance data and robust quality controls given the systemic risks revealed by past supply disruptions. Manufacturers that invest in resilient sourcing strategies, supplier audits, and rigorous quality management will likely strengthen trust among large health systems and group purchasing organizations. Together, these dynamics are recalibrating procurement criteria and accelerating selection of designs that minimize handling, enhance sterility assurance, and fit into diversified care pathways.

Assessing the practical consequences of tariff adjustments on sourcing decisions, supplier diversification, and operational continuity across clinical supply chains

The announcement and implementation of tariff measures affecting medical device components have introduced additional complexity into procurement and sourcing decisions. Tariffs can amplify the cost sensitivity of hospital purchasing and create incentives to reconsider geographical sourcing, nearshoring, and supplier diversification. For manufacturers and distributors, the cumulative impact of tariff adjustments in 2025 may prompt renegotiation of supplier contracts, reassessment of component sourcing strategies, and accelerated exploration of alternative materials that are not subject to the same duty structures.

Beyond immediate cost considerations, tariffs affect inventory management and capital allocation. Organizations may elect to increase strategic safety stocks or enter into longer-term fixed-price contracts to insulate clinical operations from price volatility. At the same time, manufacturers could respond by localizing certain stages of production or qualifying additional suppliers to minimize exposure to trade policy shifts, which would support continuity but also require investment in validation and quality oversight.

Clinically, any shift in supplier base or material composition must be managed carefully to avoid unintended consequences for compatibility with existing administration systems or for patient safety. Therefore, regulatory liaison, change control, and cross-functional decision-making become more salient as tariff-related responses are executed. In sum, tariff dynamics in 2025 will act as a catalyst for strategic supply chain adjustments, elevating the importance of contractual agility and supplier resilience.

Segment-level analysis illuminating how product configuration, application environment, end-user needs, and material selection shape design and commercialization strategies

Segmentation insights reveal differentiated imperatives for product design, regulatory strategy, and market positioning. Based on Product Type, market study spans Multi Chamber and Single Chamber configurations, with Multi Chamber further characterized by 2 Chamber, 3 Chamber, and 4+ Chamber variants; these distinctions matter because they determine the degree of pre-formulation flexibility, on-demand mixing requirements, and the potential to reduce bedside manipulation for complex regimens. In parallel, Based on Application, the market is examined across Ambulatory Care, Home Care, and Hospital settings, each of which imposes distinct priorities around portability, label clarity, and stability under variable handling conditions.

Further nuance emerges when the market is viewed Based on End User, where Ambulatory Surgical Centers, Clinics, Home Care providers, and Hospitals each maintain unique procurement cycles, clinical competencies, and regulatory oversight. Hospitals often emphasize integration with pharmacy compounding processes and centralized quality assurance, whereas home care providers prioritize ease of use, caregiver instructions, and compatibility with home infusion pumps. Clinics and ambulatory surgical centers sit between these poles, seeking solutions that deliver both clinical precision and operational simplicity.

Material selection also intersects with segmentation, as the market is studied Based on Material across Polyolefin and Polyvinyl Chloride. Polyolefin formulations are increasingly considered for reduced extractables and improved compatibility with lipid and amino acid solutions, while polyvinyl chloride continues to be used where cost and established supply chains maintain advantages. Understanding these segmentation axes enables more targeted product development and commercialization strategies that match technical attributes to user needs and regulatory expectations.

Regional contrasts and strategic implications of regulatory environments, procurement behaviors, and care delivery models across major global markets

Regional dynamics introduce important variations in regulatory regimes, procurement practices, and care delivery models. In the Americas, purchasing decisions are influenced by integrated health systems, strong hospital networks, and an emphasis on infection prevention and operational efficiency, which drives interest in single-use solutions that reduce compounding burden and risk. Regulatory frameworks in this region emphasize device safety, sterile processing standards, and documented supply chain controls, creating an environment where product evidence and supplier reliability carry significant weight.

Europe, Middle East & Africa exhibit a mosaic of regulatory sophistication and purchasing power, with leading European markets enforcing rigorous conformity assessments and clinical documentation while many countries in the Middle East and Africa prioritize reliable supply and cost-effective options. This regional diversity creates opportunities for modular product lines that can be adapted to local regulatory pathways and payer expectations, and it also emphasizes the need for flexible distribution strategies to reach disparate healthcare infrastructures.

Asia-Pacific presents a complex picture of rapid healthcare expansion, varying reimbursement models, and differing levels of domestic manufacturing capacity. In several markets across the region, growing investment in home healthcare and ambulatory services is expanding demand for user-friendly infusion solutions. Simultaneously, local production capabilities and regional trade dynamics influence sourcing decisions, and suppliers that can align with regional regulatory requirements and local clinical practices will find competitive advantage. These regional considerations affect go-to-market sequencing and the prioritization of regulatory and commercial resources.

Competitive landscape characterized by materials expertise, regulatory proficiency, and service-oriented differentiation that influence procurement choices and partnership models

Competitive dynamics in the disposable nutrition infusion bag landscape are driven by product differentiation, materials expertise, and the ability to demonstrate supply chain reliability. Leading companies that succeed combine deep regulatory knowledge with investments in quality systems and manufacturing scale, enabling them to bring validated products to clinical end users with minimal friction. Strategic partnerships between device makers, ingredient suppliers, and contract manufacturers are increasingly common, allowing for faster qualification of alternative materials and the scaling of multi-chamber formats.

Innovation pathways that resonate with buyers include designs that simplify bedside administration, reduce the need for on-site compounding, and minimize compatibility issues with infusion pumps. Manufacturers are also enhancing labeling and instruction clarity to support use across home and ambulatory settings. Service elements such as vendor-managed inventory, expedited replenishment, and transparent traceability add commercial value and strengthen long-term customer relationships.

Investment in environmental lifecycle initiatives is an emerging differentiator. Companies that can credibly reduce packaging waste, adopt recyclable materials where feasible, or demonstrate meaningful reductions in the environmental footprint of their disposable products will appeal to health systems with sustainability mandates. Ultimately, competitive advantage accrues to organizations that align technical performance, regulatory compliance, and commercial service offerings with the operational realities of diverse healthcare delivery settings.

Practical and prioritized strategic moves to enhance product uptake, fortify supply chains, and align commercial offers with clinical and sustainability objectives

Actionable recommendations for industry leaders focus on pragmatic steps that balance clinical imperatives, supply resilience, and commercial viability. First, prioritize design features that reduce bedside handling and support safe administration across hospital, ambulatory, and home care environments. Clear user-centric labeling and simplified mixing mechanisms will lower training burden and enhance adoption in decentralized care models. Concurrently, validate material choices for extractables and leachables early in the development lifecycle to streamline regulatory submissions and minimize post-market change controls.

Second, strengthen supply chain resilience through supplier diversification, strategic nearshoring of critical components, and enhanced quality oversight. Building modular qualification pathways for alternative materials will permit more nimble responses to trade or tariff disruptions. Engage in proactive contract structures that allow for flexibility in pricing and delivery windows while maintaining clinical continuity. Third, invest in commercial programs that combine product quality with services such as vendor-managed inventory, traceability dashboards, and targeted education for caregivers who support home-based infusion.

Finally, incorporate environmental considerations into product strategy in a measured way that aligns with customer expectations. Pilot programs to evaluate recyclable or lower-impact packaging and transparent lifecycle assessments will help reconcile sustainability objectives with clinical safety and regulatory demands. Taken together, these actions provide a practical roadmap to strengthen market position and to deliver products that meet evolving clinical and procurement standards.

A mixed-methods approach combining stakeholder interviews, regulatory review, and cross-validation to ensure rigorous and actionable market intelligence

The research methodology integrates qualitative and quantitative techniques to assemble a robust evidence base and to triangulate insights across stakeholders. Primary research included structured interviews with clinical leaders, procurement managers, and supply chain specialists to capture real-world priorities and operational constraints. These conversations informed the development of standardized assessment frameworks used to compare product attributes, regulatory readiness, and service capabilities across suppliers.

Secondary research drew on regulatory guidance documents, peer-reviewed literature on device materials and sterility, and industry publications that describe care delivery trends and operational requirements. Data on trade, procurement behaviors, and clinical practice patterns were synthesized to understand how external factors such as supply disruptions and policy changes influence decision-making. Cross-validation steps involved comparing primary interview themes with documented regulatory expectations and supplier quality practices to ensure consistency and reliability.

Analytical rigor was maintained through a systematic approach to source evaluation, with attention to recency, relevance, and methodological transparency. Assumptions and limitations were explicitly recorded to support informed interpretation of findings, and sensitivity checks were conducted where qualitative variability could materially influence strategic implications. This mixed-method approach yields insights grounded in practitioner experience and validated against public regulatory and clinical references.

Synthesis of clinical, materials, and supply chain findings demonstrating how multi-dimensional strategies will determine long-term competitiveness and adoption

The conclusion synthesizes the primary themes that have emerged across clinical practice, materials science, and supply chain strategy. Disposable nutrition infusion bags are positioned at the intersection of safety, convenience, and operational efficiency, and their adoption is shaped by evolving care models that prioritize decentralization and infection prevention. Material decisions, particularly the choice between polyolefin and polyvinyl chloride, remain central to product performance and regulatory dialogue, and multi-chamber configurations continue to offer compelling clinical advantages for complex formulations.

In a landscape influenced by trade policy shifts and heightened procurement scrutiny, organizational agility in sourcing and manufacturing will be a key determinant of continuity and competitiveness. Companies that align product innovation with robust quality systems, clear clinical evidence, and responsive commercial services will be best placed to support diverse end users across hospitals, clinics, ambulatory surgical centers, and home care settings. Finally, integrating sustainability considerations in ways that do not compromise sterility or clinical performance will increasingly differentiate responsible suppliers.

Taken together, these conclusions point to a market where technical refinement, supply resilience, and service-oriented commercialization define long-term success, and where proactive cross-functional collaboration within organizations accelerates the pathway from product development to clinical integration.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Disposable Nutrition Infusion Bags Market, by Product Type

  • 8.1. Multi Chamber
    • 8.1.1. 2 Chamber
    • 8.1.2. 3 Chamber
    • 8.1.3. 4+ Chamber
  • 8.2. Single Chamber

9. Disposable Nutrition Infusion Bags Market, by Material

  • 9.1. Polyolefin
  • 9.2. Polyvinyl Chloride

10. Disposable Nutrition Infusion Bags Market, by Application

  • 10.1. Ambulatory Care
  • 10.2. Home Care
  • 10.3. Hospital

11. Disposable Nutrition Infusion Bags Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Home Care
  • 11.4. Hospitals

12. Disposable Nutrition Infusion Bags Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Disposable Nutrition Infusion Bags Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Disposable Nutrition Infusion Bags Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Disposable Nutrition Infusion Bags Market

16. China Disposable Nutrition Infusion Bags Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. AdvaCare Pharma, Inc.
  • 17.6. B. Braun Melsungen AG
  • 17.7. Baxter International Inc.
  • 17.8. Becton, Dickinson and Company
  • 17.9. Cisen Pharmaceutical Co., Ltd.
  • 17.10. Fresenius Kabi AG
  • 17.11. Grifols, S.A.
  • 17.12. Huaren Pharmaceutical Co., Ltd.
  • 17.13. ICU Medical, Inc.
  • 17.14. Otsuka Pharmaceutical Co., Ltd.
  • 17.15. PolyCine GmbH
  • 17.16. Renolit SE
  • 17.17. Romsons International Pvt. Ltd.
  • 17.18. Shandong Weigao Group Medical Polymer Company Limited
  • 17.19. Shijiazhuang Pharmaceutical Group Co., Ltd.
  • 17.20. Sippex S.A.
  • 17.21. Technoflex SAS
  • 17.22. Terumo Corporation
  • 17.23. Wipak Group

LIST OF FIGURES

  • FIGURE 1. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MULTI CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MULTI CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MULTI CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY 2 CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY 2 CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY 2 CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY 3 CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY 3 CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY 3 CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY 4+ CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY 4+ CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY 4+ CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY SINGLE CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY SINGLE CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY SINGLE CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY POLYOLEFIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY POLYOLEFIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY POLYOLEFIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY POLYVINYL CHLORIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY POLYVINYL CHLORIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY POLYVINYL CHLORIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. MIDDLE EAST DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. AFRICA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. GCC DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GCC DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. GCC DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 108. GCC DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 109. GCC DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. GCC DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. BRICS DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. BRICS DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. G7 DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. G7 DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. G7 DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 126. G7 DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 127. G7 DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. G7 DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. NATO DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. NATO DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. NATO DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 132. NATO DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 133. NATO DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. NATO DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. UNITED STATES DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. UNITED STATES DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 140. UNITED STATES DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. UNITED STATES DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. CHINA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. CHINA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. CHINA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 145. CHINA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 146. CHINA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. CHINA DISPOSABLE NUTRITION INFUSION BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)